|Bid||75.01 x 800|
|Ask||75.82 x 800|
|Day's Range||75.49 - 77.13|
|52 Week Range||51.51 - 82.55|
|Beta (5Y Monthly)||0.88|
|PE Ratio (TTM)||64.38|
|Earnings Date||Oct. 21, 2020 - Oct. 26, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||85.47|
TMO vs. EW: Which Stock Is the Better Value Option?
Despite coronavirus-hit sales, Edwards Lifesciences (EW) witnessed steady improvement in TAVR procedure volumes in Q2. Regulatory approvals look encouraging.
Investors might not be overly excited about Edwards Lifesciences' (NYSE: EW) stock performance so far in 2020. Edwards Lifesciences announced its second-quarter results after the market closed on Thursday, and the stock jumped 5% in after-hours trading.